← Leaderboards
Justin Pritchard
Pennsylvania State University, The
$3,219,748
Attributed
$3,219,748
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $736.5K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,219,748 · 2
By mechanism
U01$2,591,489 · 1
R21$628,259 · 1
Top collaborators
No co-investigators on record.
Most similar at Pennsylvania State University, The
Same institution · by research overlap
- Edward C. Holmes$1,502,914
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesMalignant Neoplasm Of LungEpidermal Growth Factor ReceptorFightingLeadLeftDrug ResistanceEngineering DesignBiologicalFailureDrug DiscoveryHeterogeneityDimerizationBystander EffectCombatDrug DevelopmentDual Switch Selection Gene DriveEngineeringCell KillingCellsCell TherapyEvolutionDesignMalignant Neoplasms
Grant awards (13)
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$347,360
U01 · FY2025 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$100,263
U01 · FY2025 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$430,636
U01 · FY2024 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$92,887
U01 · FY2024 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$92,887
U01 · FY2024 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$445,665
U01 · FY2023 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$95,465
U01 · FY2023 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$95,465
U01 · FY2023 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$428,442
U01 · FY2022 · CA · contact PI
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer$462,419
U01 · FY2021 · CA · contact PI
Model Driven Construction of Dual-switch Selection Gene Drives to Combat Drug Resistance$274,055
R21 · FY2021 · EB · contact PI
Model Driven Construction of Dual-switch Selection Gene Drives to Combat Drug Resistance$274,274
R21 · FY2020 · EB · contact PI
Model Driven Construction of Dual-switch Selection Gene Drives to Combat Drug Resistance$79,930
R21 · FY2019 · EB · contact PI